These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 7684551

  • 1. Effect of growth hormone treatment on hormonal parameters, body composition and strength in athletes.
    Deyssig R, Frisch H, Blum WF, Waldhör T.
    Acta Endocrinol (Copenh); 1993 Apr; 128(4):313-8. PubMed ID: 7684551
    [Abstract] [Full Text] [Related]

  • 2. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men.
    Taaffe DR, Pruitt L, Reim J, Hintz RL, Butterfield G, Hoffman AR, Marcus R.
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1361-6. PubMed ID: 7525633
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Supraphysiological growth hormone: less fat, more extracellular fluid but uncertain effects on muscles in healthy, active young adults.
    Ehrnborg C, Ellegård L, Bosaeus I, Bengtsson BA, Rosén T.
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):449-57. PubMed ID: 15807876
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of continuous infusion of insulin-like growth factor I and II, alone and in combination with thyroxine or growth hormone, on the neonatal hypophysectomized rat.
    Glasscock GF, Hein AN, Miller JA, Hintz RL, Rosenfeld RG.
    Endocrinology; 1992 Jan; 130(1):203-10. PubMed ID: 1370151
    [Abstract] [Full Text] [Related]

  • 9. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
    Bang P, Brismar K, Rosenfeld RG, Hall K.
    J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
    [Abstract] [Full Text] [Related]

  • 10. Changes in subcutaneous and visceral fat mass during growth hormone replacement therapy in adult men.
    de Boer H, Blok GJ, Voerman B, Derriks P, van der Veen E.
    Int J Obes Relat Metab Disord; 1996 Jun; 20(6):580-7. PubMed ID: 8782736
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4.
    Donahue LR, Beamer WG.
    J Endocrinol; 1993 Jan; 136(1):91-104. PubMed ID: 7679139
    [Abstract] [Full Text] [Related]

  • 12. Does growth hormone allow more efficient nitrogen sparing in postoperative patients requiring parenteral nutrition? A double-blind, placebo-controlled randomised trial.
    Sevette A, Smith RC, Aslani A, Kee AJ, Hansen R, Barratt SM, Baxter RC.
    Clin Nutr; 2005 Dec; 24(6):943-55. PubMed ID: 16083996
    [Abstract] [Full Text] [Related]

  • 13. The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender.
    Johannsson G, Bjarnason R, Bramnert M, Carlsson LM, Degerblad M, Manhem P, Rośen T, Thorén M, Bengtsson BA.
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1575-81. PubMed ID: 8636370
    [Abstract] [Full Text] [Related]

  • 14. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [Abstract] [Full Text] [Related]

  • 15. Ontogeny of pituitary regulation of growth in the developing rat: comparison of effects of hypophysectomy and hormone replacement on somatic and organ growth, serum insulin-like growth factor-I (IGF-I) and IGF-II levels, and IGF-binding protein levels in the neonatal and juvenile rat.
    Glasscock GF, Gin KK, Kim JD, Hintz RL, Rosenfeld RG.
    Endocrinology; 1991 Feb; 128(2):1036-47. PubMed ID: 1703478
    [Abstract] [Full Text] [Related]

  • 16. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M, Hilding A, Baxter RC, Degerblad M, Wivall-Helleryd IL, Hall K.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [Abstract] [Full Text] [Related]

  • 17. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.
    Svensson J, Lönn L, Jansson JO, Murphy G, Wyss D, Krupa D, Cerchio K, Polvino W, Gertz B, Boseaus I, Sjöström L, Bengtsson BA.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):362-9. PubMed ID: 9467542
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factors and their binding proteins in plasma and milk after growth hormone-stimulated galactopoiesis in normally lactating women.
    Breier BH, Milsom SR, Blum WF, Schwander J, Gallaher BW, Gluckman PD.
    Acta Endocrinol (Copenh); 1993 Nov; 129(5):427-35. PubMed ID: 7506471
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.